Abstract |
Early cytomegalovirus (CMV) replication (eCMV) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been suggested as an independent factor that reduces leukemia relapse risk. We retrospectively analyzed 74 patients with acute myeloid leukemia (AML) who underwent allo-HSCT between August 2006 and September 2012. All recipients were CMV seropositive. In 52 patients, eCMV occurred at a median of 35 days (range, 11-92) after allo-HSCT. Univariate analysis revealed that the factors associated with a reduction in the 5-year cumulative incidence of relapse (CIR) included the first complete remission status at allo-HSCT, non-adverse cytogenetics and molecular abnormalities, pre-transplant serum ferritin level <1,400 mg/dL, chronic graft-versus-host disease (cGVHD), and eCMV. In sub-group analysis, according to the existence of eCMV and cGVHD, those with both eCMV and cGVHD showed the lowest 5-year CIR (P < 0.003). Patients with both eCMV and cGVHD had the best outcome for leukemia-free survival (LFS) (P < 0.001) and OS (P < 0.001). In the CMV-seropositive population, the presence of eCMV in combination with cGVHD had a significant positive effect on LFS and OS after allo-HSCT. When eCMV preceded cGVHD, the relapse rate after allo-HSCT was significantly reduced in patients with AML. Therefore, we suggest that it is critical to have an immunological understanding of the graft-versus- leukemia effect in this setting.
|
Authors | Ji Eun Jang, Soo Jeong Kim, June-Won Cheong, Shin Young Hyun, Yun Deok Kim, Yu Ri Kim, Jin Seok Kim, Yoo Hong Min |
Journal | Annals of hematology
(Ann Hematol)
Vol. 94
Issue 2
Pg. 275-82
(Feb 2015)
ISSN: 1432-0584 [Electronic] Germany |
PMID | 25135450
(Publication Type: Journal Article)
|
Topics |
- Acute Disease
- Adolescent
- Adult
- Cytomegalovirus
(immunology, physiology)
- Cytomegalovirus Infections
(blood, immunology, virology)
- Female
- Follow-Up Studies
- Graft vs Host Disease
(etiology, immunology, virology)
- Hematopoietic Stem Cell Transplantation
(adverse effects, methods)
- Host-Pathogen Interactions
(immunology)
- Humans
- Kaplan-Meier Estimate
- Leukemia, Myeloid
(immunology, therapy, virology)
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Recurrence, Local
(immunology, virology)
- Outcome Assessment, Health Care
(methods, statistics & numerical data)
- Proportional Hazards Models
- Retrospective Studies
- Time Factors
- Transplantation, Homologous
- Virus Replication
(immunology)
- Young Adult
|